Scavenger Receptors: Promiscuous Players during Microbial Pathogenesis by Pombinho, R et al.
REVIEW ARTICLE 
 
Scavenger Receptors: Promiscuous Players During Microbial Pathogenesis 
 
Rita Pombinhoa, Sandra Sousaa, Didier Cabanesa* 
 
a Instituto de Investigação e Inovação em Saúde, i3S; Instituto de Biologia Molecular e Celular, 
IBMC; Group of Molecular Microbiology; Universidade do Porto; Porto, Portugal 
 
Contact: *Didier Cabanes; didier@ibmc.up.pt; Rua Alfredo Allen, 208, 4200-135 Porto, Portugal 
 
 
Abstract 
Innate immunity is the most broadly effective host defense, being essential to clear the majority of 
microbial infections. Scavenger Receptors comprise a family of sensors expressed in a multitude of host 
cells, whose dual role during microbial pathogenesis gained importance over recent years. SRs regulate 
the recruitment of immune cells and control both host inflammatory response and bacterial load. In turn, 
pathogens have evolved different strategies to overcome immune response, avoid recognition by SRs and 
exploit them to favor infection. Here, we discuss the most relevant findings regarding the interplay 
between SRs and pathogens, discussing how these multifunctional proteins recognize a panoply of ligands 
and act as bacterial phagocytic receptors.  
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Scavenger Receptors: an emergent family of Pattern Recognition Receptors 
Host cells are effective guardians of the immune response through the expression of complex 
surveillance systems, including the Pattern Recognition Receptors (PRRs) (Pluddemann et al. 2011). 
SRs include a diverse and evolutionary conserved family of PRRs that are functionally and structurally 
distinct. They are soluble or cell surface associated proteins originally implicated on the recognition and 
binding of modified lipoproteins. Indeed, the scavenger activity of these receptors was first associated 
to their ability to bind and internalize oxidized low-density lipoproteins (Brown and Goldstein 1979). 
Oxidized low-density lipoproteins were implicated in the pathogenesis of atherosclerosis by challenging 
normal homeostasis (Kzhyshkowska et al. 2012). By recognizing specific epitopes, SRs can differentiate 
between unaltered and modified self-molecules (Greaves and Gordon 2009). However, the range of 
ligands that SRs recognize is extremely diverse and it is now appreciated that SRs eliminate a number 
of altered self- and non-self-ligands (extensively reviewed elsewhere) (Areschoug and Gordon 2008, 
2009; Mukhopadhyay and Gordon 2004; Pluddemann et al. 2006). Diverse cell processes ranging from 
endocytosis to phagocytosis or macropinocytosis are usually undertaken to eliminate unwanted ligands 
and maintain homeostasis (Prabhudas et al. 2014). Importantly, SRs are widely expressed in cells 
patrolling potential portals of pathogen entry, such as macrophages, neutrophils, dendritic cells, 
microglia and B cells, but they are also expressed in endothelial and epithelial cells (Mukhopadhyay 
and Gordon 2004; Murphy et al. 2005; Platt and Gordon 2001). Currently, SRs are categorized into 10 
classes (A-J) grouped according to their sequence similarity or common structural features (Fig. 1) 
(Prabhudas, et al. 2014). Several SRs have been reported to play opposite roles during bacterial 
infection: whereas at portals of pathogen invasion SRs recognize a myriad of microbial proteins 
activating downstream immune responses to fight and eliminate the pathogen, some pathogens hijack 
SRs function exploiting them to bind and invade cells, thus promoting intracellular survival and 
proliferation. Having in mind that SRs have a primordial role to maintain homeostasis by controlling 
cell integrity, which may impact pathogen infection (Trahtemberg and Mevorach 2017), this review 
focuses on SRs as an emergent family of PRRs, and their interplay with different pathogens to either 
promote an effective innate immune response or by the contrary, favor microbial pathogenesis. 
 
Scavenger Receptors from Class A  
Class A SR includes five membrane proteins containing a collagen-like domain with collagen-binding 
activity (Fig. 1) (Gowen et al. 2001; Kodama et al. 1990; Zani et al. 2015). These proteins are primarily 
expressed in tissue-resident macrophages and dendritic cells (Hughes et al. 1995). Their role in bacterial 
pathogenesis was essentially reported for Scavenger Receptor A (SR-A) and Macrophage Receptor with 
Collagenous Structure (MARCO). 
 
SR-A 
SR-A has long been shown to bind to Escherichia coli lipopolysaccharide (LPS) and lipoteichoic acids 
from some Gram-positive bacteria and was thus suggested to be implicated in host defense (Dunne et al. 
1994; Hampton and Raetz 1991). Further studies revealed its involvement in the pathogenesis of different 
microorganisms and importantly, pointed to the dual role of SR-A in infection, either by favoring the host 
response contributing to pathogen elimination or by promoting pathogen survival and dissemination.  
In particular, SR-A was reported to be detrimental for the host during Mycobacterium tuberculosis (Mtb) 
infection of alveolar macrophages. Indeed, SR-A knock-out (KO) mice display increased survival to 
pulmonary tuberculosis (Ulrichs and Kaufmann 2006). Histopathology analysis of infected lungs showed 
Mtb within cholesterol clefts and multinucleated foam cells in SR-A KO mice, whilst necrotic 
macrophages obstructing alveolar and bronchial spaces were detected in wild type (WT) mice (Sever-
Chroneos et al. 2011). In addition, the analysis of cell populations in infected lungs revealed increased 
recruitment of CD4+ lymphocytes and antigen-presenting cells (APCs) in SR-A KO mice, suggesting SR-
A as a negative regulator of pulmonary adaptive immunity during chronic Mtb infection (Fig. 2) (Sever-
Chroneos, et al. 2011). SR-A was also reported to be disadvantageous for the host during Cryptococcus 
neoformans and Pneumocystis carinii infections. As described for Mtb infection, SR-A KO mice 
displayed improved pulmonary fungal clearance, which is intimately associated with stronger 
accumulation of CD4+ T cells and CD11b+ myeloid cells in the lungs (Hollifield et al. 2007; Qiu et al. 
2013). Together, these reports suggest that SR-A confers an advantage for pathogens infecting host lungs 
and reinforce the idea that SRs can be exploited by pathogens to promote their survival within the host. 
SR-A KO mice were less prone to Brucella abortus infection, which is attributed to decreased bacterial 
internalization and intracellular replication within SR-A-deficient macrophages (Kim et al. 2004). SR-A 
was also implicated in the non-opsonic phagocytosis of two major Gram-positive pathogens, 
Streptococcus agalactiae (GBS) and Streptococcus pyogenes, by murine bone marrow-derived 
macrophages. The polysaccharide capsule or the bacterial surface lipoprotein Blr of GBS and the surface 
M protein of S. pyogenes were shown to prevent SR-A-mediated recognition and non-opsonic 
phagocytosis (Fig. 2) (Areschoug and Gordon 2008; Carlsson et al. 2005). 
Reversely, SR-A also appears to be crucial to protect the host from pathogen damage. Neisseria 
meningitidis binds bone marrow-derived macrophages almost exclusively through SR-A and 
independently from LPS, suggesting that SR-A-expressing macrophages may be critical in the innate host 
immune response to meningococci (Peiser et al. 2002). Additionally, binding assays aiming to uncover 
SR-A ligands identified three N. meningitidis proteins: NMB1220, NMB0278 and NMB0667 (Fig. 2). 
Soluble forms of these proteins were shown to block the binding of meningococci to CHO cells stably 
transfected with SR-A. Nevertheless, the authors claimed that only NMB1220 induced SR-A-mediated 
endocytosis in macrophages (Peiser et al. 2006). SR-A-mediated phagocytosis of viable N. meningitidis 
highly stimulates DCs, considered the first line of defense against invading N. meningitidis, and the 
release of pro-inflammatory cytokines, including TNF-α, IL-1β and IL-6 (Fig. 2). Interestingly, SR-A was 
reported transiently dephosphorylated shortly after meningococci contact, suggesting that SR-A 
engagement in response to bacterial binding elicits intracellular signaling to trigger a cellular response 
(Villwock et al. 2008). Importantly, N. meningitidis infected SR-A KO mice showed reduced survival as 
compared to WT mice, exhibiting higher levels of bacteremia and circulating IL-6, which is commonly 
associated with meningococcal septicemia in humans (Fig. 2) (Pluddemann et al. 2009; Prins et al. 1998). 
Additionally, the lack of SR-A was reported to impair host survival against infections by Mycoplasma 
pulmonis and Staphylococcus aureus (Fig. 2) (Booth et al. 2014; Thomas et al. 2000). 
Concerning Listeria monocytogenes infection, different studies pointed to the beneficial role of different 
SR-A isoforms in host protection. SR-AI (SR-A1) KO mice showed higher susceptibility to L. 
monocytogenes infection, with highly increased bacterial burden and decreased host survival (Suzuki et 
al. 1997). The increased susceptibility of SR-AI KO mice to L. monocytogenes infection was related with 
a defect in the uptake or killing of bacteria by macrophages (Fig. 2) (Suzuki, et al. 1997). Mice KO for 
both SR-AI and SR-AII (SR-A1.1) were also shown to be more susceptible to L. monocytogenes infection 
and displayed increased hepatic granuloma formation regarding their number, dimension and persistence 
throughout the infection (Fig. 2) (Ishiguro et al. 2001). Concomitantly, Kupffer cells and peritoneal 
macrophages from SR-AI/II KO mice showed decreased L. monocytogenes phagocytosis. Moreover, the 
listericidal phagocytic activity of WT macrophages was impaired in the presence of an anti-SR-AI/II 
blocking antibody (Ishiguro, et al. 2001). SR-AI/II were thus proposed to play a crucial role in host 
defense against L. monocytogenes infection not only by acting as a receptor for its phagocytosis, but also 
by mediating listericidal mechanisms (Fig. 2) (Ishiguro, et al. 2001). 
SR-A was also suggested to orchestrate innate and adaptive immune response to specific infections. 
Indeed, SR-A was elegantly shown to directly interact with interferon-regulatory factor 5 (IRF5) in 
Schistosoma japonicum infected macrophages, thus impairing IRF5 nuclear translocation, interfering 
with macrophage polarization and ultimately stimulating T-helper responses from type 2. In this context, 
SR-A acts to modulate macrophage polarization and fine-tune T-cell differentiation. SR-A KO mice 
displayed exacerbated death upon S. japonicum infection (Z. Xu et al. 2017).  
Pulmonary surfactant is composed by a variety of lipids and proteins, including surfactant protein A (SP-
A), which prevents alveoli collapsing during expiration (Kuroki and Voelker 1994). It was reported that 
SP-A increases cell surface localization of SR-A and potentiates SR-A-mediated phagocytosis of 
Streptococcus pneumoniae by alveolar macrophages promoting bacterial clearance (Kuronuma et al. 
2004). In agreement, SR-A KO mice displayed increased mortality rate upon S. pneumoniae infection, 
possibly due to an impaired phagocytosis, that lead to reduced clearance of live bacteria from the lungs 
and highly increased lung inflammation (Fig. 2) (Arredouani et al. 2006). Altogether, the data compiled 
above show that SR-A enhances host resistance to several pathogens, being essential to limit the severity 
of certain infections. 
Other reports point to the interplay between SR-A and other pathogens, however specific outcomes in 
the context of infection need further analysis. Clostridium perfringens, which has the ability to survive 
within murine macrophage-like cell lines (O'Brien and Melville 2000), was shown to bind to CHO cells 
in a SR-A-dependent manner (Fig. 2) (O'Brien and Melville 2003). Porphyromonas gingivalis induces 
the expression of SR-A by macrophages (Bodet et al. 2007). This increase is partially dependent on the 
major fimbriae of P. gingivalis FimA and promotes TNF-α, thus suggesting a role for SR-A in 
inflammation (Fig. 2) (Baer et al. 2009). 
Finally, SR-A was reported to act as a receptor for pathogen phagocytosis. This was shown for 
Escherichia coli and Francisella tularensis in dendritic cells and macrophages, respectively (Amiel et 
al. 2007; Pierini 2006). Binding and phagocytosis of yeast Saccharomyces cerevisiae and Candida 
albicans was also shown to be dependent on SR-A (Fig. 2) (Wang and Chandawarkar 2010). In addition, 
SR-A was shown to bind bacterial DNA (Zhu et al. 2001) and double-stranded RNA (DeWitte-Orr et al. 
2010; Limmon et al. 2008) and was involved in virus recognition, namely in the uptake of Adenovirus 
type 5 (Ad5) and endocytosis of Adeno-associated virus serotype 8 (Haisma et al. 2009; van Dijk et al. 
2013).  
SR-A appears thus as a SR capable to recognize a wide range of microbes, and contributes to pathogen 
containment by modulating the recruitment and activation of phagocytic cells and regulating 
inflammatory response through cytokine secretion. To counteract this function, some microbes evolved 
strategies to evade SR-A dependent recognition and phagocytosis. 
 
MARCO 
MARCO (SR-A6) has also an ambiguous involvement in pathogen infections, either being beneficial or 
detrimental for the host response. It is constitutively expressed in specific macrophage subpopulations 
and was primarily reported to bind soluble LPS and intact Gram-positive and Gram-negative bacteria. 
(Elomaa et al. 1995; Sankala et al. 2002). Recent studies deployed an effort to clarify the impact of this 
SR in infection. The lack of MARCO was shown to induce different outcomes upon SR interaction with 
bacteria, virus, fungus and even parasites. 
MARCO induces increased morbidity and mortality of mice with Influenza A associated pneumonia, 
due to a diminished neutrophilic inflammatory response (Ghosh et al. 2011). In addition, it is exploited 
by Herpes Simplex Virus type 1 glycoprotein C to promote cell surface adsorption and infection in the 
skin (Fig.3) (MacLeod et al. 2013). These data suggest that MARCO suppresses an early inflammatory 
response against these viral infections. Curiously, MARCO was shown to significantly enhance 
Adenovirus infection, contributing to an efficient innate virus recognition by macrophages, that in turn 
potentiates a pro-inflammatory response (Maler et al. 2017).  
In opposition, MARCO improves host resistance and promotes pathogen clearance through its capacity 
to recognize, bind and internalize different bacteria. MARCO KO mice intranasally infected with 
Streptococcus pneumoniae displayed a diminished survival rate, due to an impaired ability to clear 
bacteria from the lungs and consequently increased pulmonary inflammation (Fig. 3). Both in vitro 
binding of S. pneumoniae and in vivo uptake of non-opsonized particles were drastically impaired in 
MARCO KO alveolar macrophages (Arredouani et al. 2004). Later, MARCO was revealed crucial 
against S. pneumoniae in the murine model, MARCO KO mice showing a defect on bacterial clearance 
from the nasopharynx. In addition, MARCO deficiency abrogates cytokine production and cellular 
recruitment to the nasopharynx following colonization. Maximal TLR2- and NOD2-dependent NF-κB 
activation was shown to be MARCO-dependent (Fig. 3) (Dorrington et al. 2013). 
Regarding Mycobacterium tuberculosis (Mtb), MARCO-deficient macrophages are unable to mount an 
efficient inflammatory response to bacterial infection. MARCO, which is a tethering receptor for the cell 
wall glycolipid TDM (trehalose 6,6′-dimycolate) of Mtb, presumably presents lipids to the CD14/TLR2 
complex (Bowdish et al. 2009). MARCO is essential for phagocytosis of Mycobacterium marinum by 
zebrafish macrophages, being crucial to control bacterial growth and inflammatory response (Benard et 
al. 2014). Moreover, peritoneal macrophages from MARCO KO mice showed impaired Clostridium 
sordellii phagocytosis, which correlated with MARCO KO mice being more susceptible to C. sordellii 
uterine infection (Thelen et al. 2010). MARCO also efficiently contributes to limit Cryptococcus 
neoformans infection, controlling the recruitment of monocytes and dendritic cells and regulating the 
levels of IFN-γ. Additionally, MARCO is involved in C. neoformans phagocytosis by resident pulmonary 
macrophages and dendritic cells (Xu et al. 2017). These findings confer an important role for MARCO 
as a phagocytic receptor essential to clear pathogens.  
Microbial infection is intimately associated with an increased MARCO expression, which suggests its 
role in host defense. In vivo studies showed a transient but substantial expression of MARCO in liver 
Kupffer cells and red pulp macrophages of the spleen following intravenous infection by Listeria 
monocytogenes (Fig. 3) (Ito et al. 1999). In line with this, MARCO/SR-A double KO mice 
intraperitoneally inoculated with L. monocytogenes displayed slightly higher bacterial loads in the spleen 
and liver than the WT mice, although WT and KO mice showed equal survival rates (Chen et al. 2010). 
The expression of MARCO is also rapidly induced on macrophages, including Kupffer cells, upon 
Bacillus Calmette-Guérin (BCG) infection or injection of purified LPS (van der Laan et al. 1999), and 
in response to both in vitro and in vivo Leishmania major infections. L. major infection of macrophages 
is partially reduced in vitro by specific anti-MARCO monoclonal antibody, supporting a role of MARCO 
in macrophage infection by this parasite (Fig. 3) (Gomes et al. 2009). Besides macrophages, a strong 
increase in MARCO expression was reported in astrocytes during meningococcal-associated meningitis, 
showing that Neisseria meningitidis induces glial cell activation via MARCO (Fig. 3) (Braun et al. 2011). 
Given that MARCO has the ability to recognize N. meningitidis independently from LPS (Mukhopadhyay 
et al. 2006) glial cell activation may dependent on specific meningococcal components. 
Contrarily, the lipoprotein PpiA of Streptococcus mutans negatively regulates the expression of 
MARCO at the transcriptional and translational levels, which in turn contributes for the suppression of 
MARCO-mediated phagocytosis by macrophages (Fig. 3) (Mukouhara et al. 2011). 
So far, MARCO has been involved in the recognition and pathogenesis of both Gram-positive and Gram-
negative bacteria, parasites, fungi and various viruses. It usually behaves as a protective molecule for the 
host, stimulating phagocytosis, cellular recruitment and cytokine production. Several studies have shown 
that MARCO is differentially regulated/expressed in response to certain pathogens, suggesting its 
potential as a host innate immune receptor. This SR is also overcome and/or exploited by some pathogens 
to promote infection. 
 
Other class A SRs 
Among the less characterized members of SRs class A, SCARA5 (SR-A5), which is exclusively expressed 
by epithelial cells, was reported to bind heat-killed Escherichia coli and Staphylococcus aureus (Jiang 
et al. 2006) and SRCL (SR-A4) has the ability to bind and phagocytose bacteria and yeast, suggesting its 
possible role in host defense (Jang et al. 2009; Nakamura et al. 2001; Ohtani et al. 2001). 
 
Scavenger Receptors from class B  
The members that belong to class B SRs are characterized by the presence of two transmembrane domains 
flanking an extracellular loop, with both the amino and carboxyl terminal located within the cytosol (Fig. 
1) (Asch et al. 1987). CD36 is the prototype of class B SR and has been largely involved in microbial 
pathogenesis. 
 
CD36 
CD36 (SR-B2) senses both Gram-positive LTA and Gram-negative LPS, acting as a phagocytic receptor 
for a number of pathogenic bacteria, such as Escherichia coli, Klebsiella pneumoniae, Salmonella 
typhimurium, Staphylococcus aureus and Enterococcus faecalis (Fig. 4) (Baranova et al. 2008). 
Bacterial chaperonin 60, GroEL, and LPS potentially contribute to bacteria-induced inflammation by 
triggering SR-Bs (SR-BI, SR-BII and CD36), which mediate inflammatory signaling thus strongly 
impacting innate immunity and host defense (Baranova et al. 2012). CD36 has a protective role in skin 
infections caused by Hla-producing S. aureus which are characterized by a local inflammatory response 
that often precedes the formation of necrotic lesions. CD36 KO mice intoxicated with sterile S. aureus 
supernatant showed enhanced dermonecrosis, with increased neutrophil accumulation and local IL-1β 
expression. The contribution of neutrophils to tissue injury was confirmed since dermonecrosis is almost 
abolished upon neutrophil depletion (Fig. 4) (Castleman et al. 2015). CD36 also provides host protection 
against Klebsiella pneumoniae and Streptococcus pneumoniae intrapulmonary infections, modulating 
host inflammatory response and enhancing macrophage phagocytosis (Olonisakin et al. 2016; Sharif et 
al. 2013).  
In turn, CD36 was also reported to benefit the pathogens during infection. This is the case for S. aureus 
infection of lung epithelial cells that was suggested to be driven by Tet38 efflux pump by interacting with 
CD36 (Truong-Bolduc et al. 2017), and for Listeria monocytogenes invasion of HeLa cells which 
increases by 20-fold in CD36 overexpressing cells (Vishnyakova et al. 2006). In addition, CD36 
deficiency confers resistance to Mycobacterium tuberculosis infection. CD36 KO mice display reduced 
bacterial burden in both spleen and liver, decreased density of granulomas and diminished levels of 
circulating tumor necrosis factor (TNF) (Fig. 4) (Hawkes et al. 2010). Of note, Porphyromonas gingivalis 
infected macrophages up-regulate CD36 expression via ERK/NF-kβ pathway (Liang et al. 2016).  
Regarding parasite infection, CD36 was demonstrated to be the most common target of the PfEMP1 
proteins of Plasmodium falciparum, tethering parasite-infected erythrocytes to endothelial receptors, thus 
preventing their splenic clearance and allowing increased parasitaemia (Fig. 4) (Hsieh et al. 2016). Taken 
together these data support a dual role for CD36 in infection, being useful or not for pathogen elimination. 
 
SR-B 
Several studies pointed to the involvement of SR-B in viral infection. It was previously recognized 
essential for virus uptake, cell-to-cell transmission and cross-presentation by human dendritic cells. In 
addition, SR-B expression is modulated upon cell contact with Hepatitis C virus (HCV) (Barth et al. 
2008; Fan et al. 2017; Schwarz et al. 2009).  
In bacterial infections, SR-B may act as a multi-recognition receptor crucial to potentiate host response 
or to promote pathogen invasiveness and survival. SR-BI (SR-B1) KO mice showed increased mortality 
throughout Klebsiella pneumoniae infection, which correlates with high bacterial burden in the lung and 
in the blood, increased serum cytokines, neutrophils recruitment to the infected airspace, impaired 
phagocytic clearance and markedly organ injury (Gowdy et al. 2015). 
Reversely, SR-B promotes infection by Chlamydia pneumoniae improving bacterial attachment, 
internalization and growth into epithelial cells, and by Brucella abortus increasing the phagocytic 
activity of trophoblasts giant cells (Korhonen et al. 2012; Watanabe et al. 2010). Although SR-B was 
reported to recognize Mtb, the effects in infection remain to be addressed (Schafer et al. 2009). 
SR-BI, which is a high-density lipoprotein receptor able regulate the formation of lipid domains including 
cholesterol-rich domains (Acton et al. 1996; Urban et al. 2000), was described to mediate bacterial 
adhesion and invasion to mammalian cell (Urban, et al. 2000). In a recent study using Listeria 
monocytogenes intraperitoneal mice infection, SR-BI was proposed to prevent tissue damage without 
altering pathogen burden. SR-BI would activate autophagy mechanisms to protect organs, such as the 
liver and spleen, from the collateral damage induced by antibacterial defenses (Pfeiler et al. 2016). SR-
BI-induced autophagy suppresses tissue damage by preventing necrosis at the infectious foci, stimulating 
the internalization and clearance of apoptotic cells and inhibiting extravasation and accumulation of 
neutrophils and inflammatory macrophages in infected tissues (Pfeiler, et al. 2016). 
The interplay between SR-B and parasites was also addressed. SR-BI significantly boosts hepatocyte 
permissiveness to Plasmodium falciparum, Plasmodium yoelii, and Plasmodium berghei and 
promotes parasite development. Interestingly, SR-B is responsible for the regulation of CD81 
localization at the plasma membrane, mediating a membrane rearrangement that facilitates sporozoites 
penetration (Yalaoui et al. 2008). So far, these data indicate that SR-B not only favors host response but 
also pathogen dissemination. 
 
Scavenger Receptors from classes D and I  
CD68 (SR-D1), the only member of class D SR, is a glycosylated membrane protein that belongs to the 
lysosome-associated membrane protein family (LAMP) (Fig. 1) (Song et al. 2011). Its role in microbial 
pathogenesis is largely unknown. A peptide from Plasmodium was shown to interact with CD68 at the 
surface of Kupffer cells. The exogenous addition of this peptide inhibited sporozoite entry and subsequent 
traversal of Kupffer cells and liver infection, which strongly supports a role for CD68 as a Plasmodium 
receptor in the liver (Cha et al. 2015).  
Class I SRs are also transmembrane proteins characterized by an extracellular region with multiple 
scavenger receptor cysteine-rich (SRCR) domains (Fig.1) (Kristiansen et al. 2001). Among them, CD163 
(SR-I1) is a membrane receptor exclusively expressed in monocytes and macrophages but may be shed 
from cell surface upon cell activation. It plays important roles in the down-regulation of inflammation 
(Etzerodt and Moestrup 2013), but also functions as a sensor for Gram-positive and Gram-negative 
bacteria (Fabriek et al. 2009). In particular, it was demonstrated that soluble CD163 recognizes a specific 
fragment of fibronectin bound to Staphylococcus aureus surface molecules, leading to increased 
phagocytosis and effective bacterial killing by professional phagocytes (Kneidl et al. 2012). In addition, 
interactions of CD163 with some viral species are also known. CD163 is one of the receptors for Porcine 
reproductive and respiratory syndrome virus (PRRSV) (Calvert et al. 2007) and its absence is sufficient 
to protect fetuses following maternal infection with the virus (Prather et al. 2017). The infection process 
by African swine fever virus (ASFV) and Simian hemorrhagic fever virus (SHFV) is also dependent on 
CD163 expression, being knockout cells less permissive to viral infection (Cai et al. 2015; Sanchez-Torres 
et al. 2003). Human immunodeficiency virus-1 (HIV) infection is also enhanced in macrophages through 
the induction of CD163 expression, suggesting a role for this SR as a broad viral receptor that favors 
pathogen dissemination (Tuluc et al. 2014). 
Although CD5 and CD6 are both implicated on the modulation and signalling of T and B cell receptors, 
CD5 is well adapted to interact with fungal associated ligands, while CD6 has evolved to recognize 
bacterial ones (Sarrias et al. 2007; Vera et al. 2009). T cells expressing CD5 were shown to be more 
permissive to Hepatitis C virus (HCV) infection, promoting pathogen dissemination (Sarhan et al. 2012). 
On the other hand DMBT1 (Salivary Agglutinin or gp340) was previously found to inhibit human 
immunodeficiency virus-1 (HIV-1) infection (Chu et al. 2013) and to be associated with the activation of 
the complement (Leito et al. 2011). This SR was shown to interact and agglutinate several Gram-positive 
and Gram-negative bacteria, including Streptococcus mutants (Ericson and Rundegren 1983; Madsen et 
al. 2010). Human Spα has the same domain organization as the extracellular region of CD5 and CD6 and 
may regulate monocyte activation, function and survival (Fig. 1) (Gebe et al. 1997). Human recombinant 
Spα, that is the homologue of the mouse protein AIM, was found to interact in vitro with Gram-negative 
and Gram-positive bacteria, including Listeria monocytogenes (Bessa Pereira et al. 2016; Sarrias et al. 
2005). 
 
Scavenger Receptors from classes E, F, G, H and J 
While class E of SRs includes type II membrane proteins with C-type lectin-like domains, classes F and 
H are type I membrane proteins that contain extracellular domains with multiple Epidermal Growth Factor 
(EGF)-like repeats either alone (class F) or in combination with Fasciclin and laminin EGF-like domains 
(Class H) (Fig. 1) (Politz et al. 2002; Sawamura et al. 1997). Class G is composed by a single member 
that is not structural similar with other SRs. It is a type I transmembrane glycoprotein with a CXC 
chemokine domain and a mucin-like domain (Bazan et al. 1997). The only member of class J of SRs is 
composed by a single transmembrane domain and belongs to the immunoglobulin superfamily (Fig.1) 
(Ibrahim et al. 2013). 
 
 
 
LOX-1 
LOX-1 (SR-E1) was previously implicated on adhesion of Staphylococcus aureus and Escherichia coli 
(Shimaoka et al. 2001). Its expression was shown to be up-regulated in response to Aspergillus 
fumigatus, Chlamydia pneumoniae and Herpes simplex virus I (HSV-1) infection, suggesting a role 
for LOX-1 in host defense mechanisms against pathogen infections (Campbell et al. 2013; Chirathaworn 
et al. 2004; Gao et al. 2016; Li et al. 2015; Yoshida et al. 2006). In addition, E. coli surface-associated 
GroEL is recognized by LOX-1 on macrophages, stimulating their phagocytic capacity and enhancing 
bacterial clearance (Fig. 4) (Zhu et al. 2013). OmpA from Klebsiella pneumoniae was also reported to 
bind LOX1 and SREC, activating macrophages and dendritic cells (DCs) in a TLR2-dependent way. 
Cellular recognition of K. pneumoniae OmpA activates a pro-inflammatory response beneficial for the 
host innate immune response (Jeannin et al. 2005). 
 
DECTIN-1 
Dectin-1 (SR-E2) binds to β-glucans from various fungal pathogens, usually protecting the host from 
infection. Therefore, Dectin-1 KO mice were shown to be more susceptible to infections with Candida 
albicans, Candida glabrata and Aspergillus fumigatus (Chen et al. 2017; Taylor et al. 2007; Werner et 
al. 2009). Phagocytosis stimulation, ROS and cytokine production, inflammasome activation and T 
helper cell differentiation are some of the anti-fungal responses generated by this receptor (Geijtenbeek 
and Gringhuis 2009). 
 
CD206  
The human mannose receptor, CD206 (SR-E3) is involved in the recognition of glycans at the surface of 
some pathogens, such as Mycobacterium tuberculosis, Streptococcus pneumonia, Yersinia pestis, 
Candida albicans, Pneumocystis carinii, Influenza virus and Leishmania promoting their phagocytosis 
(Medzhitov 2007). Moreover, CD206 protects against Cryptococcus neoformans infection due to its role 
in the development of CD4+ T cells that specifically work to eliminate the pathogen (Dan et al. 2008). 
 
SREC 
SREC (SR-F1) was previously described to recognize and internalize molecular chaperones and heat 
shock proteins (Gong et al. 2009). Curiously, Neisseria meningitidis expressing the serotype A of the 
major outer membrane porin PorB (PorBIA) interacts with SREC via Gp96 allowing adherence to host 
cells. However, the invasion process requires the dissociation of Gp96 from SREC, since SREC is 
masked by surface-exposed Gp96, impairing PorBIA binding (Fig. 4). In that sense, the depletion of Gp96 
from host cells prevented adherence but significantly triggered gonococcal invasion.(Rechner et al. 2007) 
Gp96 is an endoplasmic reticulum (ER) resident chaperone previously reported to modulate the 
interaction between pathogens with their host cells. It was shown to interact with the Outer Membrane 
Protein A (OmpA) of Escherichia coli and with the Vip surface protein of L. monocytogenes, thereby 
supporting invasion, however its interaction with SREC was not described in those cases (Cabanes et al. 
2005; Prasadarao et al. 2003). SREC may also have a role in Leptospirosis since it has the potential to 
bind to Leptospira LipL32, which is an immunogenic outer membrane protein (Fig. 4) (Chaemchuen et 
al. 2011). Notable is the cooperation of both SR-AI and SREC-I with TLR2 to recognize Hepatitis C 
virus non-structural protein 3 (NS3) and induce myeloid cell activation (Beauvillain et al. 2010). More 
recently, SREC-I was found to bind Staphylococcus aureus wall teichoic acids (WTAs) and mediate 
adhesion to nasal epithelial cells in vitro (Fig. 4). Additionally, the inhibition of WTA-mediated adhesion 
with a specific SREC-I antibody reduces nasal colonization in the animal model (Baur et al. 2014). 
 
SR-PSOX  
SR-PSOX (SR-G1) mediates adhesion and phagocytosis of both Gram-positive and Gram-negative 
bacteria and it was shown to play a particular role in T and NKT cells chemotaxis, suggesting a role for 
this SR in innate and adaptive immunity during microbial infection (Shimaoka et al. 2003; Xu et al. 
2005). Expression levels of this SR were associated with different pathogenic conditions. High levels 
of SR-PSOX were correlated with lung transplant recipients affected by Human Cytomegalovirus 
(HCMV) (Weseslindtner et al. 2014). In addition, a virulence factor named zonula occludens toxin, 
produced by Campylobacter concisus, induced an upregulation of SR-PSOX, which may provide some 
insights on the bacterial mechanisms that affect the host (Deshpande et al. 2016). Higher expression 
levels of this SR were also associated with a more efficient cell migration to the secondary lymphoid 
organs and infected tissues upon Leptospira infection (Domingos et al. 2017). 
 
STABILIN-1 
Stabilin-1 (SR-H1) was found to bind to Gram-positive and Gram-negative bacteria, suggesting a role 
for this receptor in the defense mechanism against bacterial infection (Adachi and Tsujimoto 2002). 
 
RAGE  
RAGE (SR-J1) plays an important role in inflammation and infection having a dual role in bacterial 
infection. It plays a detrimental role in host response to Streptococcus pneumoniae and influenza A 
virus by promoting bacterial dissemination and potentiating pulmonary inflammatory response (van 
Zoelen et al. 2009a; van Zoelen et al. 2009b). On the other hand, it has a protective role during 
Staphylococcus aureus infection promoting lung injury in the early infection phase and contributing to 
effective antibacterial defense during Klebsiella pneumoniae pneumonia (Achouiti et al. 2016; Achouiti 
et al. 2013). 
 
Conclusion 
Throughout lifetime we are permanently in contact with a multitude of microbial species, which are 
usually targeted by our immune defenses in an effective way to prevent infection. PRRs are key players 
in the initiation of the host innate immune response. SRs compose a diverse family of PRRs mainly 
expressed in cells patrolling pathogen invasion and with an increasing role in pathogen recognition and 
elimination. Whereas, some microbes developed strategies to evade SR-dependent recognition, SRs 
mainly appear as PRRs capable to recognize a wide range of microbes, and contributes to pathogen 
containment by modulating the recruitment and the activation of phagocytic cells, and regulating 
inflammatory response through cytokine secretion. Interestingly, different SRs are capable to recognize 
the same kind of ligands, and different pathogens are recognized by SRs binding various ligands. This 
suggest that, in addition to other PRRs, the host use a range of SRs to recognize specific ligands and 
activate downstream signaling pathways accordingly to their tissue-specific and cell type-specific 
expression. In the future, it will be interesting to understand the mechanisms that regulate these pathways, 
and identify potential crosstalk between SRs that recognize the same ligands or pathogens. 
It is highly probable that other/new SRs will be implicated in microbial pathogenesis, increasing our 
understanding of the host/pathogen interplay and providing crucial insights into the immune responses 
orchestrated by the host to avoid microbial predation. Understanding the complexity of this network may 
pave the way for the identification of novel targets and pathways to limit pathogenic infection by 
amplifying protective the host cell response. 
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Figure Legends 
 
Figure 1. Schematic overview of SRs families. SRs are either transmembrane or soluble proteins 
distributed into 10 classes, from A to J, according to their sequence or structural similarities. Protein and 
carbohydrate domains that compose SR members are indicated. 
 
Figure 2. The most relevant functions of SR-A in microbial pathogenesis. SR-A binds to different 
pathogen components and act as receptor for different bacteria, virus and yeasts. SR-A is a negative 
regulator of chronic Mtb, C. neoformans and P. carinii infections, as SR-A KO mice show increase 
lymphocyte and APCs recruitment. Contrarily, SR-A positively regulates immune response against S. 
pneumoniae, N. meningitidis, M. pulmonis, S. aureus and L. monocytogenes mainly by potentiating 
bacterial phagocytosis and clearance. In vitro assays show that SR-A exposed at the surface of epithelial 
cells mediates adherence to C. perfringens and in the case of N. meningitidis and P. gingivalis, SR-A 
interacts with bacterial proteins, stimulating inflammatory response. S. pyogenes and S. agalactiae display 
evasion mechanisms to avoid SR-A-mediated phagocytosis through the expression of M protein and 
polysaccharide capsule, respectively. SR-A, Scavenger Receptor A; WT, wild-type; KO, knock-down; 
LPS, lipopolysaccharide; LTA, lipoteichoic acid; dsRNA, double-stranded ribonucleic acid; DNA, 
deoxyribonucleic acid; APCs, antigen-presenting cells; FimA, fimbrillin; SP-A, surfactant protein A. See 
text for details. 
 
Figure 3. The most relevant functions of MARCO in microbial pathogenesis. MARCO binds to E. 
coli LPS and to S. aureus and, it promotes cell surface adsorption and skin infection by HSV. MARCO is 
a negative regulator of the inflammatory response against Influenza A virus. However, MARCO is 
essential for controlling host immune response to M. marinum, S. pneumoniae, C. sordellii, L. 
monocytogenes and C. neoformans infections, being WT mice or WT morpholino highly resistant to 
infection. S. pneumoniae clearance, which is MARCO-dependent, stimulates TLR2- and NOD2-
dependent NF-κB activation and signaling. MARCO expression is up-regulated in macrophages, spleen 
and glial cells in response to L. major, N. meningitides, L. monocytogenes and S. pneumoniae infections. 
The lipoprotein PpiA of Streptococcus mutans contributes to the anti-phagocytic activity mediated by 
MARCO. MARCO, macrophage receptor with collagenous structure; WT, wild-type; KO, knock-down; 
LPS, lipopolysaccharide; NOD2, nucleotide-binding oligomerization domain-containing protein 2; 
TLR2, Toll-like receptor 2; NF-kB, nuclear factor kappa B; PpiA, peptidyl-prolyl cis/trans-isomerase. 
See text for details. 
 
Figure 4. The most relevant functions of CD36, LOX-1 and SREC in microbial pathogenesis. CD36 
is a receptor for a number of Gram-positive and Gram-negative bacteria. CD36 negatively regulates 
dermonecrosis upon mice intoxication with S. aureus-producing α-hemolysin. PfEMP1 proteins of 
Plasmodium falciparum target CD36, tethering parasite-infected red-blood cells to endothelial receptors 
to avoid splenic clearance. CD36 plays a crucial role in host defense against K. pneumoniae and S. 
pneumoniae, while it diminishes mice survival upon M. tuberculosis infection. LOX-1 and SREC bind to 
E. coli and S. aureus. LOX-1 expression is increased in response to A. fumigatus, HSV and C. pneumoniae 
within different cell types. GroEL from E. coli is recognized by LOX-1 and stimulates bacterial 
phagocytosis, weather OmpA from K. pneumoniae interact with both LOX-1 and SREC to activate cells 
in a TLR2-dependent way. PorBIA from N. gonorrhoeae interacts with SREC via Gp96 allowing 
adherence to host cells. For bacterial invasion Gp96 needs to dissociate from SREC. SREC also interacts 
with LipL32 from Leptospira and with WTA of S. aureus, stimulating nasal colonization. CD36, cluster 
of differentiation 36; LOX-1, oxidized low-density lipoprotein receptor 1; SREC, scavenger receptor 
expressed by endothelial cells; WT, wild-type; KO, knock-down; RBC, red-blood cell; pfEMP1, 
Plasmodium falciparum erythrocyte membrane protein 1; TLR2, toll-like receptor 2; GroEL, large 
oligomeric chaperone; OmpA, outer membrane protein A; PorB (IA), serotype A of the major outer 
membrane porin; Gp96, glycoprotein 96; LipL32, leptospiral lipoprotein; WTA, wall teichoic acids. 
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